72/100 · Elevated
Manufactured by AAA Pharmaceutical, Inc.
Moderate Safety Concerns for MUCUS RELIEF with Higher Incidence of Serious Reactions
674 FDA adverse event reports analyzed
Last updated: 2026-05-12
MUCUS RELIEF is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by AAA Pharmaceutical, Inc.. Based on analysis of 674 FDA adverse event reports, MUCUS RELIEF has a safety score of 72 out of 100. This score indicates a relatively favorable safety profile, with fewer or less severe adverse events compared to many other tracked medications. The most commonly reported adverse reactions for MUCUS RELIEF include FATIGUE, PNEUMONIA, FALL, PAIN, DIARRHOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for MUCUS RELIEF.
Mucus Relief has a safety concern score of 72 out of 100, placing it in the elevated concern category based on analysis of FDA adverse event data. The FDA has received approximately 674 adverse event reports for this medication, which is primarily manufactured by Aaa Pharmaceutical, Inc..
The most commonly reported adverse events include Fatigue, Pneumonia, Fall. Of classified reports, 59.5% were designated as serious by the FDA, meaning they involved hospitalization, disability, or other significant medical outcomes. Serious reactions such as pneumonia, asthma, and death are reported, indicating potential severe side effects.
A high number of falls and respiratory issues (pneumonia, dyspnoea) suggest possible risks related to respiratory function. The drug has been reported to be ineffective in some cases, raising concerns about its efficacy.
Patients taking Mucus Relief should monitor for the commonly reported side effects and contact their healthcare provider if they experience any unusual symptoms. Drug interactions and misuse, such as product dose omission and off-label use, are common, warranting caution. This analysis is based on voluntary FDA adverse event reports and should not replace professional medical advice.
Mucus Relief received a safety concern score of 72/100 (elevated concern). This is based on a 59.5% serious event ratio across 279 classified reports. The score accounts for 674 total adverse event reports and 100 distinct reaction types. This elevated score indicates a notable proportion of serious adverse events and warrants careful monitoring.
Adverse event reports by sex: Female: 155, Male: 107. The most frequently reported age groups are age 71 (13 reports), age 72 (11 reports), age 69 (8 reports). These demographics reflect reporting patterns and may not represent the full patient population.
Out of 279 classified reports for MUCUS RELIEF:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
Drug interactions and misuse, such as product dose omission and off-label use, are common, warranting caution.
If you are taking Mucus Relief, here are important things to know. The most commonly reported side effects include fatigue, pneumonia, fall, pain, diarrhoea. While many of these may be mild and temporary, you should contact your healthcare provider if any symptoms are severe or persistent. Always follow the prescribed dosage and usage instructions to avoid potential side effects. Report any adverse reactions to the FDA's MedWatch program for further evaluation. If you experience a serious adverse reaction, seek emergency medical attention immediately or call 911. You can report side effects to the FDA's MedWatch program at 1-800-FDA-1088.
The FDA is monitoring the safety of MUCUS RELIEF, and further studies are ongoing to assess its safety profile.
The FDA has received approximately 674 adverse event reports associated with Mucus Relief. These reports come from healthcare professionals, consumers, and manufacturers through the FDA Adverse Event Reporting System (FAERS). Note that the number of reports does not directly indicate the frequency of side effects, as adverse events are voluntarily reported and may be underrepresented.
The most frequently reported adverse events for Mucus Relief include Fatigue, Pneumonia, Fall, Pain, Diarrhoea. By volume, the top reported reactions are: Fatigue (23 reports), Pneumonia (18 reports), Fall (17 reports). These figures reflect FDA adverse event reports and may not represent the true incidence rate of these side effects in all patients taking Mucus Relief.
Out of 279 classified reports, 166 (59.5%) were classified as serious and 113 as non-serious. The FDA classifies an event as "serious" if it results in death, hospitalization, disability, or other medically significant outcomes. A higher serious-event ratio warrants closer attention but does not necessarily mean the drug is unsafe.
Adverse event reports for Mucus Relief break down by patient sex as follows: Female: 155, Male: 107. This distribution reflects reporting patterns rather than actual risk differences between groups. Reporting rates can be influenced by prescribing patterns, disease demographics, and reporting behavior.
The most frequently reported age groups for Mucus Relief adverse events are: age 71: 13 reports, age 72: 11 reports, age 69: 8 reports, age 70: 8 reports, age 63: 7 reports. Age-related reporting patterns can reflect both the demographics of the patient population and potential age-related susceptibility to certain side effects.
The primary manufacturer associated with Mucus Relief adverse event reports is Aaa Pharmaceutical, Inc.. Multiple manufacturers may produce generic versions of this drug. The manufacturer listed reflects the most frequently reported brand in FDA adverse event data.
Beyond the most common reactions, other reported adverse events for Mucus Relief include: Dyspnoea, Product Dose Omission Issue, Covid-19, Asthma, Death. Less common side effects can still be clinically significant. Patients should report any unusual symptoms to their healthcare provider.
You can report adverse events from Mucus Relief to the FDA through their MedWatch program at www.fda.gov/medwatch, by calling 1-800-FDA-1088, or by completing Form FDA 3500. Healthcare professionals, consumers, and manufacturers can all submit reports. Reporting helps the FDA monitor drug safety after approval.
Mucus Relief has a safety concern score of 72 out of 100 (elevated concern). This score is calculated from the ratio of serious to non-serious adverse events, the diversity of reported reactions, and the overall volume of reports relative to usage. Serious reactions such as pneumonia, asthma, and death are reported, indicating potential severe side effects.
Key safety signals identified in Mucus Relief's adverse event data include: 12 reports of death among 674 total reports, indicating a significant risk.. Multiple reports of pneumonia and asthma, suggesting potential respiratory issues.. Falls and product dose omission issues are frequently reported, indicating possible misuse or side effects.. These signals are derived from patterns in FDA reports and should be discussed with a healthcare provider for personalized assessment.
Drug interactions and misuse, such as product dose omission and off-label use, are common, warranting caution. Always inform your healthcare provider about all medications, supplements, and over-the-counter drugs you are taking before starting Mucus Relief.
Always follow the prescribed dosage and usage instructions to avoid potential side effects. Report any adverse reactions to the FDA's MedWatch program for further evaluation.
Mucus Relief has 674 adverse event reports on file with the FDA. A high number of falls and respiratory issues (pneumonia, dyspnoea) suggest possible risks related to respiratory function. The volume of reports for Mucus Relief reflects both the drug's usage level and the vigilance of the reporting community.
The FDA is monitoring the safety of MUCUS RELIEF, and further studies are ongoing to assess its safety profile. For the most current regulatory information, check the FDA's drug labeling database or consult your pharmacist.
Explore other medications manufactured by AAA Pharmaceutical, Inc. and compare their safety profiles:
The following drugs share commonly reported adverse reactions with MUCUS RELIEF:
Drugs related to MUCUS RELIEF based on therapeutic use, drug class, or shared indications: